These real‐world results suggest that Humalog Jr KwikPen is prescribed in patients who may benefit from finer insulin dose adjustments, including children, adolescents, elderly people and pregnant women with T1D or T2D. This evidence concerns the gene INS and type 1 diabetes mellitus.